Nicholas Company, Inc. Charles River Laboratories International, Inc. Transaction History
Nicholas Company, Inc.
- $5.88 Billion
- Q4 2024
A detailed history of Nicholas Company, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Nicholas Company, Inc. holds 69,446 shares of CRL stock, worth $12.3 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
69,446
Previous 69,446
-0.0%
Holding current value
$12.3 Million
Previous $13.7 Million
6.29%
% of portfolio
0.22%
Previous 0.23%
Shares
15 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$900 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$721 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$386 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$320 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...